The Clinical Utility of Genetic Testing for t(8;16)(p11;p13) in Congenital Acute Myeloid Leukemia
Tomoo Daifu(Kyoto University), Souichi Adachi(Kyoto University), Ichiro Kamiya(Kyoto University), Tatsutoshi Nakahata(Kyoto University), Kagehiro Kozuki(Kyoto University), Itaru Kato(Kyoto University), Katsutsugu Umeda(Kyoto University), Tomohiko Taki(Kyorin University), Hidefumi Hiramatsu(Kyoto University), Toshio Heike(Kyoto University), Kenichiro Watanabe(University Hospital of Geneva)
Cited by 6
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
|Immunity|2009|2.3k
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
|Journal of Clinical Oncology|2015|383